相关实验视频
Updated: Jul 1, 2025

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
无毒,可生物降解的超分支多 (β-氨基) 对于高效的siRNA传递和基因沉默
Ying Jie Ooi1, Chongquan Huang1,2, Kieran Lau1
1School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637459, Singapore.
ACS applied materials & interfaces
|March 7, 2024
概括
研究人员开发了新型的超分支聚β氨基 (pBAE),用于高效的RNA干扰 (RNAi) 基因沉默. 这些新的非病毒载体显示了毒性降低和小干扰RNA (siRNA) 在挑战细胞中的增强传递.
科学领域:
- 生物材料科学 生物材料科学
- 基因治疗 基因治疗
- 纳米技术纳米技术
背景情况:
- RNA干扰 (RNAi) 提供了治疗潜力,但面临着交付挑战.
- 非病毒载体,如聚β氨基 (pBAE) 是有前途的,但往往需要高剂量,引发毒性问题.
- 优化pBAE结构对于有效和安全的siRNA传递至关重要.
研究的目的:
- 为高效的siRNA凝聚和基因沉默设计和优化超分支的pBAE.
- 与商业转染剂相比,评估这些新型pBAE的性能.
- 评估这些pBAE在向难以转移的原始细胞传递siRNA方面的潜力.
主要方法:
- 一系列具有不同单体组合和分支密度的超分支pBAE的合成和表征.
- 在体外评估siRNA凝聚,细胞毒性,细胞吸收和HeLa细胞和初级神经细胞中的基因沉默效率.
- 领先的pBAE候选物 (h(A2B3) -1) 与Lipofectamine 2000 的比较.
- 将生物可降解二硫化物键纳入聚合物骨干,以提高细胞相容性.
主要成果:
- 一种超分支的pBAE,h(A2B3)-1,在显著较低的聚合物/siRNA比率和siRNA剂量下显示出优异的siRNA凝聚和基因沉默.
- h(A2B3)-1在HeLa细胞中表现出较低的细胞毒性和比Lipofectamine 2000更高的传染效率.
- 在难以转移的原发皮质神经元 (34.8%的淘汰) 和寡干细胞原生细胞 (53.4%的淘汰) 中实现了有效的基因沉默.
- 加入二硫化物键进一步提高了细胞相容性,而不会影响转化效率.
结论:
- 超分支的pBAE,特别是h(A2B3)-1,是siRNA传递的高度有效的非病毒载体.
- 这些新型聚合物为安全有效的RNAi介导基因沉默提供了有前途的解决方案,具有临床翻译的潜力.
- 这项研究为开发下一代非病毒基因传递系统提供了宝贵的见解.
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Small interfering RNAs (siRNA)
3.5K
3.5K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K

